Gagnon Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,118
Closed -$120K 88
2025
Q4
$120K Buy
44,118
+55
+0.1% +$181 0.02% 85
2025
Q3
$186K Buy
44,063
+313
+0.7% +$1.38K 0.04% 83
2025
Q2
$218K Sell
43,750
-49,393
-53% -$215K 0.04% 81
2025
Q1
$411K Buy
93,143
+23,276
+33% +$109K 0.09% 65
2024
Q4
$325K Buy
69,867
+6,266
+10% +$34.4K 0.07% 69
2024
Q3
$441K Buy
63,601
+247
+0.4% +$1.94K 0.09% 65
2024
Q2
$494K Buy
63,354
+10,815
+21% +$80.1K 0.11% 60
2024
Q1
$373K Sell
52,539
-85
-0.2% -$562 0.09% 70
2023
Q4
$353K Buy
52,624
+825
+2% +$4.65K 0.08% 64
2023
Q3
$292K Buy
51,799
+3,784
+8% +$25.2K 0.07% 71
2023
Q2
$265K Buy
48,015
+13,115
+38% +$70.6K 0.06% 77
2023
Q1
$218K Sell
34,900
-74,398
-68% -$415K 0.05% 97
2022
Q4
$509K Buy
109,298
+76,553
+234% +$377K 0.11% 67
2022
Q3
$153K Buy
32,745
+52
+0.2% +$328 0.03% 94
2022
Q2
$194K Buy
32,693
+11,224
+52% +$125K 0.04% 97
2022
Q1
$415K Buy
21,469
+8,604
+67% +$197K 0.07% 78
2021
Q4
$420K Buy
12,865
+275
+2% +$11.1K 0.06% 80
2021
Q3
$516K Buy
12,590
+54
+0.4% +$1.96K 0.08% 79
2021
Q2
$451K Buy
12,536
+2,232
+22% +$82.4K 0.06% 80
2021
Q1
$402K Buy
+10,304
New +$463K 0.06% 82

Other funds holding GDRX

Gagnon Securities's GDRX Position: Q1 2026 in Review

Gagnon Securities sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 44,118 shares — an estimated $120K sold.

Gagnon Securities first reported a position in GDRX in Q1 2021 and held it in 20 quarters. The position peaked at $516K in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Gagnon Securities reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Gagnon Securities sold 44,118 GoodRx Holdings shares in Q1 2026, an estimated $120K.
  • Gagnon Securities first reported a position in GoodRx Holdings in Q1 2021 and held it in 20 quarters.
  • Gagnon Securities's GoodRx Holdings position peaked at $516K in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.